Drugs that contain Rotigotine

1. List of Neupro drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617591 UCB INC Transdermal delivery system for the administration of rotigotine
Jul, 2023

(5 months from now)

US8246980 UCB INC Transdermal delivery system
Nov, 2025

(2 years from now)

US8246979 UCB INC Transdermal delivery system for the administration of rotigotine
Sep, 2027

(4 years from now)

US10350174 UCB INC Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Dec, 2030

(7 years from now)

US10130589 UCB INC Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Dec, 2030

(7 years from now)

US9925150 UCB INC Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
Mar, 2032

(9 years from now)

Market Authorisation Date: 09 May, 2007

Treatment: A method for the treatment of a patient suffering from a disease treatable with rotigotine, comprising applying the claimed transdermal delivery system (tds) to the skin of the patient; Treatment of signs and symptoms of parkinson's disease by application of claimed transdermal system; Treatment of restless legs syndrome by application of claimed transdermal delivery system

Dosage: FILM, EXTENDED RELEASE;TRANSDERMAL

How can I launch a generic of NEUPRO before it's patent expiration?
More Information on Dosage

NEUPRO family patents

11

United States

9

European Union

6

China

5

Korea, Republic of

4

Japan

3

Brazil

3

Australia

3

Poland

3

Spain

3

Mexico

3

Slovenia

3

Portugal

3

Canada

3

Denmark

2

Austria

2

Hong Kong

2

Germany

2

Israel

2

South Africa

2

Norway

1

RS

1

Lithuania

1

Cyprus

1

Hungary

1

Croatia

1

EA

1

Turkey

1

ME

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic